Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
June 6, 2025: Novo Nordisk Asked to Add NAION, Which Can Cause Blindness, to Ozempic Warning Label The European Medicines Agency has concluded that taking Ozempic and other medications that contain semaglutide may increase someones risk of developing NAION
In response to these findings, the European Medicines Agency (EMA) conducted a review and concluded that NAION is a very rare adverse reaction to semaglutide-containing products, potentially affecting up to 1 in 10,000 users
Effects of Pharmacotherapies on the -Cell Incretin Sensitivity HbA1c, hemoglobin A1c
Simon GE, Shortreed SM, Boggs JM et al (2022) Accuracy of ICD-10-CM encounter diagnoses from health records for identifying self-harm events
The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use
